Literature DB >> 975143

Pharmacological basis of the treatment of orthostatic disorders with ergot alkaloids.

E Stürmer.   

Abstract

Ergot alkaloids increase the tone of isolated canine vein strips dose-dependently in concentrations considerably lower than noradrenaline, but the maximal responses are only about one third of those to noradrenaline. This action can be blocked by prior administration of phentolamine. It is therefore concluded that the long-lasting stimulant action of ergot alkaloids on vascular smooth muscle is mediated mainly by alpha-adrenoceptors. Using the autoperfused hind limb of the cat, it has been shown that dihydroergotamine increases dose-dependently the tone of the capacitance vessels in a manner very similar to electrical stimulation of the sympathetic nerve with increasing frequencies. However, in contrast to sympathetic nerve stimulation, dihydroergotamine elicits only a very weak increase in arteriolar resistance.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 975143     DOI: 10.1159/000169822

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  2 in total

1.  Treatment of orthostatic hypotension with dihydroergotamine.

Authors:  G Jennings; M Esler; R Holmes
Journal:  Br Med J       Date:  1979-08-04

2.  Effects of dihydroergotamine (DHE) on blood flow and metabolism in the underperfused myocardium in anaesthetized dogs.

Authors:  R Seitelberger; W Schütz; G Raberger
Journal:  Basic Res Cardiol       Date:  1984 Jul-Aug       Impact factor: 17.165

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.